Search research articles
Contact Us
Filters
Showing results (1511-1520 of 1,679) with videos related to
Page
of 168
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2022
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
V Subbiah, R J Kreitman, Z A Wainberg, et al.
Molecular Imaging and Biology
|
April 16, 2016
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P Rowe, Katarzyna J Macura, Esther Mena, et al.
Molecular Cell
|
October 7, 2017
Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent
Marco Jost, Yuwen Chen, Luke A Gilbert, et al.
Infection
|
February 2, 2021
Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia
Thomas L Walsh, Derek N Bremmer, Matthew A Moffa, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
August 4, 2015
Angiographic factors associated with haemorrhagic presentation of brain arteriovenous malformation in a Chinese paediatric population
Elaine W S Fok, W L Poon, K S Tse, et al.
Magnetic Resonance in Medicine
|
October 26, 2016
Voxelwise analysis of simultaneously acquired and spatially correlated <sup>18</sup> F-fluorodeoxyglucose (FDG)-PET and intravoxel incoherent motion metrics in breast cancer
Jason Ostenson, Akshat C Pujara, Artem Mikheev, et al.
Journal of the American Chemical Society
|
March 31, 2015
Charge Transport across DNA-Based Three-Way Junctions
Ryan M Young, Arunoday P N Singh, Arun K Thazhathveetil, et al.
Biomacromolecules
|
September 13, 2012
Preparation of cationic nanogels for nucleic acid delivery
Saadyah E Averick, Eduardo Paredes, Ainara Irastorza, et al.
Alimentary Pharmacology & Therapeutics
|
February 23, 2017
Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease
W Kim, B G Kim, J S Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2006
A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors
Elizabeth Fox, John M Maris, Brigitte C Widemann, et al.
Page
of 168
Search research articles
Search
Showing results (1511-1520 of 1,679) with videos related to
Sort By:
Page
of 168
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2022
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study
V Subbiah, R J Kreitman, Z A Wainberg, et al.
Molecular Imaging and Biology
|
April 16, 2016
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
Steven P Rowe, Katarzyna J Macura, Esther Mena, et al.
Molecular Cell
|
October 7, 2017
Combined CRISPRi/a-Based Chemical Genetic Screens Reveal that Rigosertib Is a Microtubule-Destabilizing Agent
Marco Jost, Yuwen Chen, Luke A Gilbert, et al.
Infection
|
February 2, 2021
Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia
Thomas L Walsh, Derek N Bremmer, Matthew A Moffa, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
August 4, 2015
Angiographic factors associated with haemorrhagic presentation of brain arteriovenous malformation in a Chinese paediatric population
Elaine W S Fok, W L Poon, K S Tse, et al.
Magnetic Resonance in Medicine
|
October 26, 2016
Voxelwise analysis of simultaneously acquired and spatially correlated <sup>18</sup> F-fluorodeoxyglucose (FDG)-PET and intravoxel incoherent motion metrics in breast cancer
Jason Ostenson, Akshat C Pujara, Artem Mikheev, et al.
Journal of the American Chemical Society
|
March 31, 2015
Charge Transport across DNA-Based Three-Way Junctions
Ryan M Young, Arunoday P N Singh, Arun K Thazhathveetil, et al.
Biomacromolecules
|
September 13, 2012
Preparation of cationic nanogels for nucleic acid delivery
Saadyah E Averick, Eduardo Paredes, Ainara Irastorza, et al.
Alimentary Pharmacology & Therapeutics
|
February 23, 2017
Randomised clinical trial: the efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease
W Kim, B G Kim, J S Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2006
A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors
Elizabeth Fox, John M Maris, Brigitte C Widemann, et al.
Page
of 168